APAC Realty Limited (SGX:CLN)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions SGD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	250	138	179	210	256	158
Market Cap Growth	17.59%	-22.90%	-14.41%	-18.06%	61.80%	-9.18%
Enterprise Value	242	145	193	215	266	181
Last Close Price	0.70	0.37	0.46	0.51	0.55	0.31
PE Ratio	18.02	19.18	15.23	7.89	7.23	9.62
Forward PE	14.39	11.16	13.08	8.50	7.30	11.04
PS Ratio	0.39	0.25	0.32	0.30	0.35	0.40
PB Ratio	1.53	0.88	1.13	1.31	1.59	1.02
P/TBV Ratio	4.52	2.85	3.80	3.73	3.99	2.77
P/FCF Ratio	10.31	16.40	11.24	6.39	4.76	7.96
P/OCF Ratio	10.00	15.10	10.37	5.97	4.66	7.89
PEG Ratio	-	0.65	0.65	0.65	0.65	0.65
EV/Sales Ratio	0.38	0.26	0.35	0.31	0.36	0.46
EV/EBITDA Ratio	10.28	10.30	10.00	5.41	5.69	8.55
EV/EBIT Ratio	12.64	14.35	12.47	5.92	6.08	9.23
EV/FCF Ratio	9.98	17.16	12.11	6.55	4.95	9.13
Debt / Equity Ratio	0.24	0.26	0.28	0.29	0.32	0.36
Debt / EBITDA Ratio	1.69	2.85	2.20	1.12	1.04	2.41
Debt / FCF Ratio	1.64	4.93	2.78	1.41	0.94	2.79
Asset Turnover	1.85	1.68	1.52	1.82	2.09	1.27
Quick Ratio	1.15	1.13	1.10	0.91	1.10	1.12
Current Ratio	1.16	1.16	1.14	0.93	1.20	1.27
Return on Equity (ROE)	8.71%	4.12%	6.64%	16.47%	22.39%	10.89%
Return on Assets (ROA)	3.46%	1.89%	2.65%	5.86%	7.74%	3.99%
Return on Capital (ROIC)	5.92%	3.13%	4.73%	10.87%	12.99%	5.92%
Return on Capital Employed (ROCE)	9.30%	5.00%	7.60%	22.00%	20.80%	9.40%
Earnings Yield	5.75%	5.21%	6.56%	12.67%	13.84%	10.40%
FCF Yield	9.70%	6.10%	8.90%	15.65%	21.03%	12.57%
Dividend Yield	3.83%	5.62%	5.40%	12.32%	13.52%	8.13%
Payout Ratio	99.71%	113.78%	116.14%	100.32%	52.69%	43.22%
Buyback Yield / Dilution	0.21%	-2.09%	-1.67%	-	-	-
Total Shareholder Return	4.04%	3.53%	3.74%	12.32%	13.52%	8.13%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.